Introducere. Cancerul pulmonar (CP) a devenit la sfîrşitul secolului XX una dintre principalele cauze mondiale de deces. În pofida metodelor contemporane diagnosticul precoce al CP rămîne o problemă nerezolvată. Scopul lucrării. Evaluarea aspectelor clinice şi paraclinice ale cancerului pulmonar. Material şi metode. A fost efectuat un studiu prospectiv şi retrospectiv, care a inclus 38 pacienţi de ambele sexe cu vârsta medie 58±3,5 ani, aflați la tratament în IMSP SCM „Sf. Arhanghel Mihail” în perioada 2012-2014. Datele au fost prelucrate în programul Microsoft Excel 2007. Statistica simplă, prin determinarea procentajului şi mediei. Rezultate. Bărbaţi/Femei – 84,2%/15,8%; fumători – 33 (86,8%) pacienţi. Tuse, dispnee, astenie – 38 (100%) pacienţi; dureri toracice – 20 (52,6%) pacienți; hemoptizie – 13 (34,2%) pacienți. Radiologic: infiltrat pulmonar – 13 (34,2%) pacienţi, fibroză pulmonară – 10 (26,3%) bolnavi, CP – 4 (10,5%) pacienți; endoscopic: CP – 5 (13,1%) pacienţi; citologie pozitivă – 8 (21%) pacienţi; CP central – 25 (65,7%) pacienţi, CP periferic – 13 (34,2%) pacienţi, lobii superiori fiind cei mai afectaţi. Concluzii. Debutul CP nu este specific şi evoluează sub masca altor patologii bronhopulmonare, ceea ce determină stabilirea tardivă a CP.

Introduction. At the end of the 20 th century the Lung Cancer (LC) became one of the world main causes of death. Despite modern treatment methods the early LC diagnosis remains an unresolved problem. Objective of the study. Evaluation of clinical and paraclinical aspects of the lung cancer. Material and methods. A prospective and retrospective study has been performed on 38 patients of both genders aged 58±3,5 years. Such patients were treated at the IMSP MCH "Sf. Arhanghel Mihail" during 2012-2014. The data was processed in Microsoft Excel 2007. The applied statistical method was simple by establishing the percentage and average number. Results. Men/Women – 84.2%/15.8%; smokers – 33 (86.8%) patients. Cough, dyspnea, asthenia – 38 (100%) patients; chest pains – 20 (52.6%) patients; haemoptysis – 13 (34.2%) patients. Radiologically: pulmonary infiltrated – 13 (34.2%) patients, pulmonary fibrosis – 10 (26.3%) patients, LC – 4 (10.5%) patients; endoscopically: LC – 5 (13.1%) patients; positive cytology – 8 (21%) patients; central LC – 25 (65.7%) patients, peripheral LC -13 (34.2%) patients, upper lung lobes are the most frequently affected. Conclusions. The LC onset isn’t specific and it develops under other bronchial and pulmonary pathologies, that determined the late LC establishment.